Acute poisoning in children; a population study in isfahan, iran, 2008-2010

Farzad Gheshlaghi1, Mohammad-Reza Piri-Ardakani, Mansooreh Yaraghi

  • 1Department of Clinical Toxicology and Forensic Medicine, Isfahan University of Medical Sciences, Isfahan, Iran ; Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Acute accidental poisoning in children remains a public health concern. Pharmaceutical drugs are the leading cause, with lethargy as a common symptom, necessitating thorough toxicology screening in emergency departments.

Area of Science:

  • Pediatric Emergency Medicine
  • Toxicology
  • Public Health

Background:

  • Acute accidental poisoning in children is a significant global health issue.
  • Epidemiological data is crucial for understanding and addressing poisoning patterns.
  • This study focuses on the current trends of acute poisoning in children.

Purpose of the Study:

  • To investigate the epidemiological patterns of acute accidental poisoning in children.
  • To identify the most common agents and clinical presentations.
  • To inform public health strategies and clinical management.

Main Methods:

  • Retrospective study design.
  • Analysis of children under 10 years old admitted to two teaching hospitals' Emergency Departments over two years.
  • Data collection on poisoning agents, clinical signs, and outcomes.

Main Results:

  • 344 children were admitted for acute accidental poisoning.
  • Pharmaceutical drugs were the most frequent cause (58.1%), followed by hydrocarbons (13.1%) and opioids (9.3%).
  • Neurological signs were common (42.6%), with lethargy being most prevalent (39.1%). Most children were discharged within 6-12 hours without complications.

Conclusions:

  • Accidental poisonings continue to cause significant morbidity in children, particularly in developing nations.
  • The high incidence of pharmaceutical poisoning highlights the need for enhanced preventive measures.
  • Comprehensive toxicology screening is recommended for children presenting with life-threatening events, given the prevalence of drug-induced lethargy.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...